At AMIA, clinical decision support is seen as the key to wider use of PGx and greater efficacy
WASHINGTON — Molecular labs, health systems, electronic health record providers, and clinical decision support content creators seem to agree that pharmacogenomics is one of many necessary components of precision medicine, but the promise cannot be realized until it becomes an inconspicuous part of clinicians’ workflow. That was the main message of a lively panel discussion …